TMO

#69
Thermo Fisher Scientific, Inc.
510.71 USD
+2.95%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
510.07
511.08
Rango anual
385.46
643.99
Cambio diario
+2.95%
Variación mensual
+8.57%
Variación en los últimos 6 meses
-2.17%
Cambio anual
+14.12%
Cierres anteriores
496.09
Abrir
510.64
Bid
Ask
Mínimo
510.07
High
511.08
Volumen
414
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 189.72 B
  • Employee 125 K
  • Founded N/A
  • CEO Marc N. Casper
  • Website www.thermofisher.com
  • Headquarter Delaware, United States
  • FIGI BBG000BVDLH9
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
32.66
Relación precio/flujo de caja
4.92
Dividendos por acción
1.72
Rendimiento por dividendo, %
0.3

Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation, Alfa Aesar, Affymetrix, FEI Company, BD Advanced Bioprocessing, and PPD. It ranked 104th on the Fortune 500 list based on its 2024 annual revenue of $42.879 billion. Thermo Fisher announced a $2 billion investment over four years in the U.S., including $1.5 billion for expanding manufacturing capacity and $500 million for R&D investment. This initiative aims to bolster domestic biotech manufacturing, create high-paying jobs, and reinforce the U.S. healthcare supply chain.

Noticias